Dementia is not a single disease but a group of conditions that gradually damage brain function—most commonly Alzheimer’s, vascular dementia, and Lewy body dementia.

While no cure exists, emerging studies suggest mesenchymal stem cells (MSCs) may help slow decline by reducing inflammation and improving neuronal communication.
At EDNA Wellness, we use umbilical-cord-derived MSCs (UC-MSCs) processed in TISTR-certified GMP laboratories, following published dosage and safety standards to ensure credibility and patient trust.

Understanding Dementia

Dementia describes a decline in memory, language, reasoning, and daily-function ability severe enough to interfere with independence.
Main causes include:

• Alzheimer’s disease (≈ 60–70 %)
• Vascular dementia – post-stroke blood-flow injury
• Lewy body dementia – abnormal α-synuclein buildup
• Frontotemporal dementia – degeneration of frontal and temporal lobes

These conditions share one feature: progressive loss of neurons due to chronic inflammation, oxidative stress, and toxic protein accumulation.

Current Treatments and Limitations

Existing medications—such as cholinesterase inhibitors or memantine—improve symptoms temporarily but cannot reverse neuronal loss. Lifestyle interventions (exercise, diet, cognitive training) are essential yet often insufficient once degeneration begins. This is why researchers worldwide are testing regenerative therapies like stem-cell infusions to restore a healthier brain environment

How Stem Cells May Work in Dementia

Mesenchymal stem cells act mainly through biological signaling rather than direct neuron replacement:

1. Neuro-inflammation control – MSCs reduce cytokines (IL-1β, TNF-α) and microglial overactivation.
2. Growth-factor secretion – BDNF, VEGF, and NGF support neuroplasticity and blood flow.
3. Amyloid and oxidative-stress clearance – MSC exosomes help remove toxic proteins and free radicals
4. Mitochondrial protection – improves energy metabolism in surviving neurons

Together, these mechanisms aim to stabilize cognitive function and delay further neuron death.

Scientific Evidence to Date

• Pre-clinical research: Animal models of dementia show that UC-MSC transplantation enhances learning and memory tasks and reduces neuroinflammation.
• Human pilot trials: Small studies of intravenous MSCs in mixed-dementia patients report good tolerance and mild cognitive improvement.
• From analysis: Across 10 clinical trials, stem-cell therapy demonstrated safety and short-term cognitive stabilization in mild-to-moderate dementia.

Although still early-phase, the consistent finding is safety and neuro-supportive potential.

Administration Routes and Clinical Protocols

Route	Purpose	Advantages	Limitations
Intravenous (IV)	Systemic immune modulation	Non-invasive, quick recovery	Limited brain penetration
Intrathecal (Spinal)	Direct cerebrospinal delivery	Higher CNS bioavailability	Requires lumbar puncture
Intranasal (Experimental)	Targeted olfactory transport	Needle-free, promising in models	Human data limited

At EDNA Wellness, treatment plans are tailored individually, combining IV and local delivery only when medically indicated, never exceeding peer-reviewed dosage ranges.

Expected Results

Patients may notice:

• Weeks 1–4: improved alertness or sleep quality.
• Months 2–6: better attention span, reduced agitation.
• Beyond 6 months: slower cognitive decline and higher daily-function stability.

Because dementia has many sub-types, EDNA Wellness focuses on functional stabilization and quality of life, not miracle promises.

Safety & Regulatory Oversight

• UC-MSCs are produced under Thai GMP standards with full sterility, viability, and endotoxin testing.
• Doses follow research-backed ranges (1–2 × 10⁷ cells per session).
• No steroids or unverified additives are mixed with cells.
• All patients undergo neurological screening and follow-up assessment.

Adverse effects in published studies are mild—temporary headache, fatigue, or back discomfort—without long-term complications

Cautions for Patients and Families

• Confirm that the supervising physician is a neurologist or regenerative-medicine specialist.
• Ask for proof of cell origin, quantity, and GMP certificate.
• Avoid clinics promoting unproven “memory reversal within weeks.”
• Seek ethical programs with documented research references

Lifestyle Support Remains Essential

Even with regenerative support, daily habits make a difference:

• Exercise – increases brain-derived neurotrophic factor.
• Mediterranean-style diet – high in antioxidants.
• Sleep hygiene – 7–8 hours for amyloid clearance.
• Social connection – reduces depression and cognitive isolation.

EDNA Wellness integrates these behavioral pillars into every care plan.

Stem-cell therapy offers genuine scientific hope for people living with dementia by creating a calmer, better-nourished brain environment. While research is still ongoing, early evidence shows UC-MSCs can slow cognitive loss safely when applied under strict standards.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Chen, Y., Lee, S., & Wu, K. (2024). Mitochondrial protection by mesenchymal stem cells in neurodegenerative disease models. Stem Cells Translational Medicine, 13(2), 190–202.
• Choi, H., Kim, Y., & Park, S. (2024). Clinical safety and cognitive outcomes after intravenous MSC therapy in dementia. Frontiers in Aging Neuroscience, 16, 120–135.
• Kim, H. J., Lee, M. J., & Oh, S. H. (2022). Mesenchymal stem cell infusion improves cognitive function in patients with mild to moderate Alzheimer’s disease: A phase I/II study. Stem Cells Translational Medicine, 11(8), 789–798.
• National Institute on Aging. (2024). Dementia overview and treatment research. U.S. Department of Health and Human Services.
• World Health Organization. (2023). Global status report on dementia 2023. Geneva: WHO Press.
• Zhang, L., Wang, P., & Chen, X. (2023). Mesenchymal stem cells reduce neuroinflammation and improve cognition in animal models of dementia. Stem Cell Research & Therapy, 14(1), 102.